1. Home
  2. CRBU vs UFI Comparison

CRBU vs UFI Comparison

Compare CRBU & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • UFI
  • Stock Information
  • Founded
  • CRBU 2011
  • UFI 1969
  • Country
  • CRBU United States
  • UFI United States
  • Employees
  • CRBU N/A
  • UFI N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • UFI Textiles
  • Sector
  • CRBU Health Care
  • UFI Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • UFI Nasdaq
  • Market Cap
  • CRBU 93.0M
  • UFI 88.5M
  • IPO Year
  • CRBU 2021
  • UFI N/A
  • Fundamental
  • Price
  • CRBU $0.77
  • UFI $4.68
  • Analyst Decision
  • CRBU Strong Buy
  • UFI
  • Analyst Count
  • CRBU 5
  • UFI 0
  • Target Price
  • CRBU $10.60
  • UFI N/A
  • AVG Volume (30 Days)
  • CRBU 1.0M
  • UFI 87.9K
  • Earning Date
  • CRBU 05-08-2025
  • UFI 04-30-2025
  • Dividend Yield
  • CRBU N/A
  • UFI N/A
  • EPS Growth
  • CRBU N/A
  • UFI N/A
  • EPS
  • CRBU N/A
  • UFI N/A
  • Revenue
  • CRBU $9,918,000.00
  • UFI $590,261,000.00
  • Revenue This Year
  • CRBU N/A
  • UFI $1.03
  • Revenue Next Year
  • CRBU $163.34
  • UFI $18.80
  • P/E Ratio
  • CRBU N/A
  • UFI N/A
  • Revenue Growth
  • CRBU N/A
  • UFI 2.51
  • 52 Week Low
  • CRBU $0.66
  • UFI $4.25
  • 52 Week High
  • CRBU $4.21
  • UFI $7.91
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 43.66
  • UFI 42.31
  • Support Level
  • CRBU $0.73
  • UFI $4.40
  • Resistance Level
  • CRBU $0.91
  • UFI $5.54
  • Average True Range (ATR)
  • CRBU 0.08
  • UFI 0.31
  • MACD
  • CRBU 0.01
  • UFI -0.05
  • Stochastic Oscillator
  • CRBU 24.34
  • UFI 23.93

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

Share on Social Networks: